Cardiovascular Risk in Toledo Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3125 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study on Nutrition and Cardiovascular Risk in Spain.

NCT01133093

Cardiovascular Disease

COMPLETED

European Study of Cardiovascular Risk

NCT00882336

Cardiovascular Risk Factors Hyperlipidemia Hypertension +3 more

COMPLETED

Improving Prevention of Heart Disease in Latinos

NCT00101530

Cardiovascular Diseases Heart Diseases Hypertension +1 more

COMPLETED

Metabolomics, Genomics and Nutrition for Cardiovascular Disease Precision Medicine

NCT05706519

Ischemic Heart Disease Coronary Heart Disease

UNKNOWN

Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention

NCT01889030

Cardiovascular Primary Prevention

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.

Clinical history, physical examination and complementary tests are being performed.

Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.

CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.

Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factor Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort of the study

A sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.

Observational

Intervention Type OTHER

This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender

Exclusion Criteria

* Individulas aged under 18 years.
* Subjects who do not sign the informed consent.
* Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes